Human Microbiome Drug TargetsGenevieve Dable-Tupas, Rohini Karunakaran, Peter Paul C Lim, Maria Catherine B OteroHäftad, 20242 929 kr
Valore diagnostico e prognostico della procalcitonina nei pazienti affetti da tubercolosiRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Wartośc diagnostyczna i prognostyczna prokalcytoniny u pacjentów z gruźlicąRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Valor diagnóstico e prognóstico da procalcitonina em pacientes com tuberculoseRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Diagnostischer und prognostischer Wert von Procalcitonin bei TB-PatientenRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Diagnostischer und prognostischer Wert von Procalcitonin bei TB-PatientenRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Valor diagnóstico e prognóstico da procalcitonina em pacientes com tuberculoseRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Wartośc diagnostyczna i prognostyczna prokalcytoniny u pacjentów z gruźlicąRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Valore diagnostico e prognostico della procalcitonina nei pazienti affetti da tubercolosiRohini Karunakaran, Surekha Bhat, Srikumar Padmalayam SadanandanHäftad, 2025989 kr
Human Microbiome Drug TargetsGenevieve Dable-Tupas, Rohini Karunakaran, Peter Paul C Lim, Maria Catherine B OteroHäftad, 20242 929 kr